Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial - Kook, Hyungdon; Yu, Cheol Woong; Choi, Donghoon; Ahn, Tae Hoon; Chang, Kiyuk; Cho, Jin-Man; Kim, Soo-Joong; Park, Chang Gyu; Cho, Deok-Kyu; Kim, Sang-Hyun; Lee, Han Cheol; Jin, Han-Young; et al. (Clinical therapeutics, 2022)
Keywords: Adenosine diphosphate; Ankle; Asymptomatic; Blood pressure; Blood vessels; cilostazol; Clinical trials; Consent; Controlled release; Diabetes; Diabetic retinopathy; Double-blind studies; Drug dosages; Ginkgo biloba; Heart; Ingredients; Intermittent claudication; Internal Medicine; Ischemia; Laboratories; Leaves; Medical imaging; Mortality; Pain; Patients; peripheral arterial disease; Plant extracts; Product returns; Pulmonary embolisms; Safety; Sensation; SID142; Ulcers; Walking; Ginkgo biloba; cilostazol; peripheral arterial disease; SID142